Skip to main content
Erschienen in: Endocrine Pathology 2/2019

29.01.2019 | Thyroidectomy

Revisiting the Significance of Prominent C Cells in the Thyroid

verfasst von: Talia L. Fuchs, Stephen E. Bell, A. Chou, Anthony J. Gill

Erschienen in: Endocrine Pathology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

C cell hyperplasia is considered a precursor lesion for hereditary forms of medullary thyroid carcinoma. It has therefore been suggested as a morphological marker to distinguish hereditary from sporadic medullary thyroid carcinoma and to triage genetic testing in resource poor settings. However, numerous definitions for C cell hyperplasia have been suggested, and there is surprisingly little data regarding the number of C cells present in thyroid glands removed for conditions other than medullary carcinoma. We therefore sought to investigate the specificity of different criteria for C cell hyperplasia. We examined the number of C cells and solid cell nests (ultimobranchial body remnants) present in 118 completion thyroidectomy specimens from patients without medullary carcinoma and with no risk factors for MEN2. Morphological review was performed on all H&E-stained slides, and immunohistochemistry for calcitonin was performed on one block from each case. Solid cell nests were found in 4 (3.3%) of thyroids. Increased numbers of C cells sufficient to fulfil criteria for C cell hyperplasia were found in 5 (4.2%) to 36 (30.5%) cases depending on the criteria used. We conclude that large numbers of C cells are commonly found in thyroids not associated with medullary carcinoma. Therefore, regardless of which criteria are used, the presence of C cell hyperplasia is not a specific marker for hereditary medullary thyroid carcinoma.
Literatur
1.
Zurück zum Zitat Chan JKC (2007) Tumours of the thyroid and parathyroid glands. In: Fletcher CDM (ed) Diagnostic histopathology of tumors, 3rd edn. Churchill Livingstone Elsevier, New York, pp.1223–1232. Chan JKC (2007) Tumours of the thyroid and parathyroid glands. In: Fletcher CDM (ed) Diagnostic histopathology of tumors, 3rd edn. Churchill Livingstone Elsevier, New York, pp.1223–1232.
2.
Zurück zum Zitat Tashjian AH, Wolfe HJ, Voelkl EF (1974) Human calcitonin: immunologic assay, cytologic localization and studies on medullary thyroid carcinoma. Am J Med 56:840–849.CrossRefPubMed Tashjian AH, Wolfe HJ, Voelkl EF (1974) Human calcitonin: immunologic assay, cytologic localization and studies on medullary thyroid carcinoma. Am J Med 56:840–849.CrossRefPubMed
3.
4.
Zurück zum Zitat Harach HR (1985) Histological markers of solid cell nests of the thyroid. With emphasis on their expression in thyroid ultimobranchial-related tumors. Acta Anatomica 124:111–116.CrossRefPubMed Harach HR (1985) Histological markers of solid cell nests of the thyroid. With emphasis on their expression in thyroid ultimobranchial-related tumors. Acta Anatomica 124:111–116.CrossRefPubMed
5.
Zurück zum Zitat Gimm O, Morrison CD, Suster S et al (2004) Multiple endocrine neoplasia type 2. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, pp.211–217. Gimm O, Morrison CD, Suster S et al (2004) Multiple endocrine neoplasia type 2. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, pp.211–217.
6.
Zurück zum Zitat Reagh J, Bullock M, Andrici J, Turchini J, Sioson L, Clarkson A, Watson N, Sheen A, Lim G, Delbridge L, Sidhu S, Sywak M, Aniss A, Shepherd P, Ng D, Oei P, Field M, Learoyd D, Robinson BG, Clifton-Bligh RJ, Gill AJ (2017) NRASQ61R mutation-specific immunohistochemistry also identifies the HRASQ61R mutation in medullary thyroid cancer and may have a role in triaging genetic testing for MEN2. Am J Surg Pathol, 41:75–81.CrossRefPubMed Reagh J, Bullock M, Andrici J, Turchini J, Sioson L, Clarkson A, Watson N, Sheen A, Lim G, Delbridge L, Sidhu S, Sywak M, Aniss A, Shepherd P, Ng D, Oei P, Field M, Learoyd D, Robinson BG, Clifton-Bligh RJ, Gill AJ (2017) NRASQ61R mutation-specific immunohistochemistry also identifies the HRASQ61R mutation in medullary thyroid cancer and may have a role in triaging genetic testing for MEN2. Am J Surg Pathol, 41:75–81.CrossRefPubMed
7.
Zurück zum Zitat Saggiorato E, Rapa I, Garino F, Bussolati G, Orlandi F, Papotti M, Volante M (2007) Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia. J Mol Diag 9(2):214–219.CrossRef Saggiorato E, Rapa I, Garino F, Bussolati G, Orlandi F, Papotti M, Volante M (2007) Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia. J Mol Diag 9(2):214–219.CrossRef
8.
Zurück zum Zitat Wells SA Jr, Asa SL, Dralle H et al (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567–610.CrossRefPubMedPubMedCentral Wells SA Jr, Asa SL, Dralle H et al (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567–610.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Wolfe HJ, Melvin KEW, Cervi-Skinner SJ, al Saadi AA, Juliar JF, Jackson CE, Tashjian Jr AH (1973) C-cell hyperplasia preceding medullary thyroid carcinoma. NEJM 289:437–441.CrossRefPubMed Wolfe HJ, Melvin KEW, Cervi-Skinner SJ, al Saadi AA, Juliar JF, Jackson CE, Tashjian Jr AH (1973) C-cell hyperplasia preceding medullary thyroid carcinoma. NEJM 289:437–441.CrossRefPubMed
10.
Zurück zum Zitat Williams ED, Ponder BJ, Craig RK (1987) Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C-cell hyperplasia. Clin Endocrinol 27:107–114.CrossRef Williams ED, Ponder BJ, Craig RK (1987) Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C-cell hyperplasia. Clin Endocrinol 27:107–114.CrossRef
11.
Zurück zum Zitat Ekblom M et al (1987) Familial and sporadic medullary thyroid carcinoma: clinical and immunohistochemical findings. Quarterly Journal of Medicine 247:899–910. Ekblom M et al (1987) Familial and sporadic medullary thyroid carcinoma: clinical and immunohistochemical findings. Quarterly Journal of Medicine 247:899–910.
12.
Zurück zum Zitat Albores-Saavedra J, Monforte H, Nadji M, Morales AR (1988) C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol 19(7):795–799.CrossRefPubMed Albores-Saavedra J, Monforte H, Nadji M, Morales AR (1988) C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol 19(7):795–799.CrossRefPubMed
13.
Zurück zum Zitat LiVolsi V, DeLellis R, Komminoth P et al (2017) Multiple endocrine neoplasia type 2. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J (eds) WHO classification of tumours of endocrine organs, 4th edn. IARC Press, Lyon, pp.248–250. LiVolsi V, DeLellis R, Komminoth P et al (2017) Multiple endocrine neoplasia type 2. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J (eds) WHO classification of tumours of endocrine organs, 4th edn. IARC Press, Lyon, pp.248–250.
14.
Zurück zum Zitat Guyetant S, Rousselet M-C, Durigon M et al (1997) Sex-related C-cell hyperplasia in the normal human thyroid: a quantitative autopsy study. J Clin Endocrinol Metab 82:42–47.CrossRefPubMed Guyetant S, Rousselet M-C, Durigon M et al (1997) Sex-related C-cell hyperplasia in the normal human thyroid: a quantitative autopsy study. J Clin Endocrinol Metab 82:42–47.CrossRefPubMed
15.
Zurück zum Zitat Albores-Saavedra JA, Krueger JE (2001) C-cell hyperplasia and medullary thyroid microcarcinoma. Endocrine Pathology 12:365–377.CrossRefPubMed Albores-Saavedra JA, Krueger JE (2001) C-cell hyperplasia and medullary thyroid microcarcinoma. Endocrine Pathology 12:365–377.CrossRefPubMed
16.
Zurück zum Zitat Guyetent S, Blechet C, Saint-Andre JP (2006) C-cell hyperplasia. Annals of Endocrinology (Paris) 67:190–197.CrossRef Guyetent S, Blechet C, Saint-Andre JP (2006) C-cell hyperplasia. Annals of Endocrinology (Paris) 67:190–197.CrossRef
17.
Zurück zum Zitat Scognamiglio T (2017) C-cell and follicular epithelial cell precursor lesions of the thyroid. Arch Pathol Lab Med 141:1646–1652.CrossRefPubMed Scognamiglio T (2017) C-cell and follicular epithelial cell precursor lesions of the thyroid. Arch Pathol Lab Med 141:1646–1652.CrossRefPubMed
Metadaten
Titel
Revisiting the Significance of Prominent C Cells in the Thyroid
verfasst von
Talia L. Fuchs
Stephen E. Bell
A. Chou
Anthony J. Gill
Publikationsdatum
29.01.2019
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 2/2019
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-019-9567-6

Weitere Artikel der Ausgabe 2/2019

Endocrine Pathology 2/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie